So this brings Harry's estimate down to $6-$10 per share or a sale amount of $35-60Billion. This sounds achievable given the Seagen deal, but we have not factored in the other platforms, only CF33.
Thanks Harry for your calculations. Is 5 times revenue normal and if IMUGENE drugs are cheaper to produce and buy (assuming they also drop the price) will the 15% market share be discounted for the drop in revenue for that 15%?
Thanks all.
IMU Target $2.00 - Not Ramping !!!, page-19
-
- There are more pages in this discussion • 270 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.001(0.96%) |
Mkt cap ! $385.8M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.2¢ | $69.77K | 1.323M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 2128578 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 964608 | 16 |
View Market Depth
| Last trade - 14.01pm 19/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |